These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Genome analysis on human chromosome 14 and searching for the disease related genes]. Isobe M Tanpakushitsu Kakusan Koso; 1997 Dec; 42(17 Suppl):2714-20. PubMed ID: 9455183 [No Abstract] [Full Text] [Related]
63. [Searching for the disease related genes from human chromosome 14]. Isobe M Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2232-5. PubMed ID: 11802372 [No Abstract] [Full Text] [Related]
64. [Organization of the human T-cell receptor genes and its involvement in chromosome translocations in T-cell malignancy]. Isobe M Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):383-91. PubMed ID: 8488271 [No Abstract] [Full Text] [Related]
65. The role of TCL1 in human T-cell leukemia. Pekarsky Y; Hallas C; Croce CM Oncogene; 2001 Sep; 20(40):5638-43. PubMed ID: 11607815 [TBL] [Abstract][Full Text] [Related]
67. The Runx genes: lineage-specific oncogenes and tumor suppressors. Cameron ER; Neil JC Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187 [TBL] [Abstract][Full Text] [Related]
68. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML. Yang G; Khalaf W; van de Locht L; Jansen JH; van der Reijden BA; Müller-Tidow C; Delwel HR; Serve H; Clapp DW; Hiebert SW Ann Hematol; 2004 Jun; 83(6):329-30. PubMed ID: 15052372 [TBL] [Abstract][Full Text] [Related]
69. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Licht JD Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817 [No Abstract] [Full Text] [Related]
70. The RUNX genes: gain or loss of function in cancer. Blyth K; Cameron ER; Neil JC Nat Rev Cancer; 2005 May; 5(5):376-87. PubMed ID: 15864279 [TBL] [Abstract][Full Text] [Related]
71. Ataxia telangiectasia: a model for T-cell leukemogenesis. Stern MH Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):29-31. PubMed ID: 8511036 [TBL] [Abstract][Full Text] [Related]
72. Ciba Medal Lecture. Chromosomal abnormalities in cancer cells: identification of molecules important for tumour development. Rabbitts TH Biochem Soc Trans; 1993 Nov; 21(4):809-15. PubMed ID: 8132072 [No Abstract] [Full Text] [Related]
73. Chromosomal abnormalities in lymphoid tumours: mechanism and role in tumour pathogenesis. Rabbitts TH; Boehm T; Mengle-Gaw L Trends Genet; 1988 Nov; 4(11):300-4. PubMed ID: 3070852 [No Abstract] [Full Text] [Related]
74. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Rabbitts TH Genes Dev; 1998 Sep; 12(17):2651-7. PubMed ID: 9732263 [No Abstract] [Full Text] [Related]
75. Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer. Minna JD; Schütte J; Viallet J; Thomas F; Kaye FJ; Takahashi T; Nau M; Whang-Peng J; Birrer M; Gazdar AF Int J Cancer Suppl; 1989; 4():32-4. PubMed ID: 2530182 [No Abstract] [Full Text] [Related]
76. [Cancer and transcriptional regulation]. Fujinaga K; Yoshida K Tanpakushitsu Kakusan Koso; 1996 Jun; 41(8 Suppl):1336-41. PubMed ID: 8741657 [No Abstract] [Full Text] [Related]
77. The molecular basis of leukemia. Cline MJ N Engl J Med; 1994 Feb; 330(5):328-36. PubMed ID: 8277954 [No Abstract] [Full Text] [Related]
78. Biology of sarcomas. Chang HA; Chung M; Terek R Med Health R I; 1997 Jan; 80(1):8-14. PubMed ID: 9009577 [No Abstract] [Full Text] [Related]